• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

607-32-9 (5-Nitroisoquinoline)

1

Identification

5-Nitroisoquinoline 5-Nitroisoquinoline
Name 5-Nitroisoquinoline
Formula C9H6N2O2
MW 174.16
CAS No. 607-32-9
EINECS 210-133-8
Smiles O=[N+]([O-])C1=CC=CC2=CN=CC=C21
Synonyms 5-nitroisoquinoline
InChI InChI=1S/C9H6N2O2/c12-11(13)9-3-1-2-7-6-10-5-4-8(7)9/h1-6H
2

Introduction

Background Information

3

Protocol(Only for Reference)

Cell Experiment

Animal Experiment

4

Physical and Chemical Properties

Appearance: EBNumber:EB000034637

Storage condition

Solubility

5

Mechanism and Indication

Signaling Pathways
Target
Research Area
Indications
6

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase
7

Safety Data of 5-Nitroisoquinoline

´╗┐Hazard Symbols : Xn
´╗┐Risk Statements : R20/21/22;R38
Safety Statements : S26;S36/37/39
WGKGermany : 3
8

Spectral Information

9

Suppliers List

10

Related Products

Other Forms of 607-32-9

Name CAS No Formula MW

Recommended Compounds in

Name CAS No Formula MW

Recommended Compounds in Same Indication

Name CAS No Formula MW
11

Route of Synthesis

12

References

Protocol Reference

13

More Information

5-Nitroisoquinoline

Tags: buy 607-32-9 IC50 | 607-32-9 price | 607-32-9 cost | 607-32-9 solubility | 607-32-9 purchase | 607-32-9 manufacturer | 607-32-9 research buy | 607-32-9 order | 607-32-9 MSDS | 607-32-9 chemical structure | 607-32-9 Storage condition | 607-32-9 molecular weight | 607-32-9 mw | 607-32-9 datasheet | 607-32-9 supplier | 607-32-9 cell line | 607-32-9 NMR | 607-32-9 MS | 607-32-9 IR | 607-32-9 solubility | 607-32-9 Safe information | 607-32-9 Qc and Spectral Information | 607-32-9 Clinical Information | 607-32-9 Clinical Trial | 607-32-9 Route of Synthesis | 607-32-9 storage condition | 607-32-9 diseases and conditions | 607-32-9 flash point | 607-32-9 boiling point | 607-32-9 melting point | 607-32-9 storage condition | 607-32-9 brand